| Nirali Shah, | |
|
352 University Ave, Palo Alto, CA 94301-1715 | |
| (650) 324-3248 | |
| Not Available |
| Full Name | Nirali Shah |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 352 University Ave, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588228472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 73997 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nirali Shah, 352 University Ave, Palo Alto, CA 94301-1715 Ph: (650) 324-3248 | Nirali Shah, 352 University Ave, Palo Alto, CA 94301-1715 Ph: (650) 324-3248 |
News Archive
Corbett Accel Healthcare Group is now CAHG, having adopted a new integrated marketing communications network model designed to deliver MarketMovingIdeas® in support of their clients' brands. Complementing the new agency network brand is a new vision, We Grow Leaders, which reflects the agency network's devotion to the development of leadership brands, ideas and talent.
Many illnesses can be reliably diagnosed through laboratory tests, but these in vitro analyses often use up valuable time. A system developed by Fraunhofer research scientists, which can carry out complex analyses on the spot, will soon be ready for the market.
OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.
› Verified 9 days ago
Dr. Laura Elizabeth Stoddard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
See Lor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Jaimini Shah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Avenue, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Tam Bang Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4170 El Camino Real, Palo Alto, CA 94306 Phone: 650-858-2007 | |
Nidhu Baby Abraham, PHARM.D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Eric Fujii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd Ste 108, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Thuy Diem Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda, Palo Alto, CA 94034 Phone: 650-493-5000 |